MedPath

Mindfulness-Based Ecological Momentary Intervention For Smoking Cessation Among Cancer Survivors

Phase 1
Active, not recruiting
Conditions
Any Cancer Type
Registration Number
NCT06476548
Lead Sponsor
H. Lee Moffitt Cancer Center and Research Institute
Brief Summary

The purpose of the study is to obtain feedback on a new quit-smoking treatment among individuals with a cancer diagnosis using a prototype app we developed.

Detailed Description

The study aims to test the usability of the prototype app in conjunction with face-to-face brief cessation counseling and nicotine replacement therapy in a single-arm trial.

Recruitment & Eligibility

Status
ACTIVE_NOT_RECRUITING
Sex
All
Target Recruitment
12
Inclusion Criteria
  • Having smoked at least one cigarette (even one or two puffs) within the past 30 days.
  • Having been diagnosed with cancer.
  • Willing to give quitting a try as part of the study.
  • Having a smartphone that allows installation of the app.
  • Willingness to download and use the app daily.
  • Valid home address and functioning phone number.
  • Being able to read, write, and speak English.
Exclusion Criteria
  • Being enrolled in a smoking cessation program.
  • Current use of smoking cessation medications.
  • Evidence of current psychosis.
  • Current/planning pregnancy or lactation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Retention RateAt 4 weeks

Percentage of participants who downloaded the study's smartphone application and attended the first counseling session.

Likability of Mindfulness PracticesAt 4 weeks

Participants will rate the likability of mindfulness practices delivered through the study app on a 6-point Likert scale from 1 (Extremely dislike) to 6 (Extremely like).

Utility of Mindfulness PracticesAt 4 weeks

Participants will rate their perceived helpfulness of mindfulness practices delivered through the study app on a 6-point Likert scale from 1 (Extremely unhelpful) to 6 (Extremely helpful).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Moffitt Cancer Center

🇺🇸

Tampa, Florida, United States

Moffitt Cancer Center
🇺🇸Tampa, Florida, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.